This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain (GET Living)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Laura Simons(Giardi), Boston Children's Hospital
ClinicalTrials.gov Identifier:
NCT01974791
First received: October 22, 2013
Last updated: April 6, 2017
Last verified: April 2017
  Purpose
The broad aim of the study is to implement and evaluate the efficacy of Graded Exposure Treatment (GET Living) to target elevated pain-related fears in children with chronic pain. Pain-related fear is an important psychological factor associated with poor outcomes in children suffering with chronic pain. To examine the efficacy of GET Living in addressing pain-related fears the investigators propose to use a sequential replicated randomized single-case experimental phase design with multiple measures. The specific aims are to 1) evaluate the effectiveness and acceptability of individually tailored GET Living for children with high pain-related fear and functional disability and 2) define anatomical and resting state connectivity patterns in the brains of children and adolescents with complex chronic pain prior to and after participation in GET Living.

Condition Intervention
Chronic Pain Neuralgia Musculoskeletal Pain Headache Behavioral: GET Living

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Treatment
Official Title: GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain

Resource links provided by NLM:


Further study details as provided by Laura Simons(Giardi), Boston Children's Hospital:

Primary Outcome Measures:
  • Decrease in Fear of Pain [ Time Frame: Decrease in Fear of Pain from Baseline to end of treatment at 6-weeks, on average ]

Secondary Outcome Measures:
  • Decrease in Functional Disability [ Time Frame: Decrease in Functional Disability from Baseline to end of treatment at 6-weeks, on average ]
  • Improvement in School Functioning [ Time Frame: Improvement in School Functioning from baseline to end of treatment at 6-weeks, on average ]
  • Decrease in Pain Catastrophizing [ Time Frame: Decrease in Pain Catastrophizing from baseline to end of treatment at 6-weeks, on average ]
  • Decrease in Pain Intensity [ Time Frame: Decrease in Pain Intensity from baseline to end of treatment at 6-weeks, on average ]
  • Increase in Physical Activity [ Time Frame: Increase in Physical Activity from baseline to end of treatment at 6-weeks, on average ]

Estimated Enrollment: 32
Study Start Date: October 2013
Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: GET Living Treatment Behavioral: GET Living
GET Living is an exposure based treatment jointly delivered by a cognitive-behavioral therapist and physical therapy to help children and adolescents suffering with chronic pain and headache progressively return to valued life activities.

  Eligibility

Ages Eligible for Study:   8 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Pain-related fear (score >40 on the Fear of Pain Questionnaire (FOPQ (Simons et al., 2011a))
  • Musculoskeletal, neuropathic limb or back pain, or headache
  • Functional limitations (score > 12 on the Functional Disability Inventory (FDI (Kashikar-Zuck et al., 2001; Walker and Greene, 1991)).

Exclusion Criteria:

  • Significant cognitive impairment (e.g., intellectual disability)
  • Serious psychopathology (e.g., active suicidality).
  • Acute trauma (e.g., spondylolithesis, disk herniation, fracture, acute tendonitis)
  • Systemic disease in active inflammatory state
  • Biomechanical deficit that would limit ability to engage in exposure activities (e.g. severe muscle atrophy)
  • Making gains in current physical therapy or have not had physical therapy, but it is clearly indicated
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01974791

Locations
United States, Massachusetts
Boston Children's Hospital Waltham
Waltham, Massachusetts, United States, 02453
Sponsors and Collaborators
Boston Children’s Hospital
Investigators
Principal Investigator: Laura E Simons, PhD Boston Children’s Hospital
  More Information

Responsible Party: Laura Simons(Giardi), Staff Psychologist, Boston Children's Hospital
ClinicalTrials.gov Identifier: NCT01974791     History of Changes
Other Study ID Numbers: IRB-P00007276
82267 ( Other Grant/Funding Number: American Pain Society )
Study First Received: October 22, 2013
Last Updated: April 6, 2017

Additional relevant MeSH terms:
Chronic Pain
Headache
Neuralgia
Musculoskeletal Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Peripheral Nervous System Diseases
Neuromuscular Diseases
Muscular Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on July 27, 2017